Clinical Trials in Cleveland

Showing 10261-10280 of 16,969 trials

Patient Reported Outcome Instruments in Sarcoidosis

NCT04342403

Evaluate change of quality of life of sarcoiodosis patients over a six months using various quality of life instruments including a monthly smart phone app.

Sarcoidosis

University of Cincinnati350 participantsStarted Apr 2017

Albany, New York, United States • Cincinnati, Ohio, United States • Cleveland, Ohio, United States

COMPLETEDNA30 miles

Intervention for Battered Sheltered Women With Substance Use Randomized Trial

NCT02629133

This study developed and assessed an innovative, high-reach, easily implementable, low-cost computer-delivered intervention (Safe and Healthy Experiences; The SHE Program) that addresses known barriers in early identification and intervention with sheltered battered women with IPV (intimate partner violence) and substance use.

Intimate Partner Violence

Women and Infants Hospital of Rhode Island50 participantsStarted Mar 2016

Attleboro, Massachusetts, United States • Akron, Ohio, United States • Providence, Rhode Island, United States +1 more locations

TERMINATED49 miles

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

NCT03705013

The primary endpoint is to obtain longitudinal information on four sub-populations from the Cologuard Post-Approval Study.

Colorectal Cancer

Exact Sciences Corporation51 participantsStarted Oct 2018

Glendale, Arizona, United States • Mesa, Arizona, United States • Tempe, Arizona, United States +17 more locations

Patient Reported Outcome Instruments in Sarcoidosis

Intervention for Battered Sheltered Women With Substance Use Randomized Trial

Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)

Find Trials by Condition in Cleveland

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer

Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery

Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Deceased Donor Biomarkers and Recipient Outcomes

Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months

Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)

Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus

A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)

Study Evaluating IGSC 20% Flexible Dosing in Treatment-Experienced and Treatment-Naive Subjects With Primary Immunodeficiency

Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes

Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)

N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence